T. Rowe Price Associates’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $71.8M | Sell |
|
|||||
|
2022
Q1 | $106M | Buy |
|
|||||
|
2021
Q4 | $182M | Buy |
|
|||||
|
2021
Q3 | $218M | Buy |
|
|||||
|
2021
Q2 | $226M | Buy |
|
|||||
|
2021
Q1 | $238M | Sell |
|
|||||
|
2020
Q4 | $310M | Buy |
|
|||||
|
2020
Q3 | $171M | Buy |
|
|||||
|
2020
Q2 | $123M | Buy |
|
|||||
|
2020
Q1 | $60M | Sell |
|
|||||
|
2019
Q4 | $93.2M | Buy |
|
|||||
|
2019
Q3 | $45.7M | Buy |
|
|||||
|
2019
Q2 | $36.2M | Buy |
|